These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27642050)

  • 21. Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.
    Yates JR; Breitenstein KA; Gunkel BT; Hughes MN; Johnson AB; Rogers KK; Shape SM
    Pharmacol Biochem Behav; 2016; 150-151():31-38. PubMed ID: 27642050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.
    Yates JR; Gunkel BT; Rogers KK; Hughes MN; Prior NA
    Psychopharmacology (Berl); 2017 Feb; 234(3):461-473. PubMed ID: 27837332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of GluN2B-selective antagonists on delay and probability discounting in male rats: Modulation by delay/probability presentation order.
    Yates JR; Prior NA; Chitwood MR; Day HA; Heidel JR; Hopkins SE; Muncie BT; Paradella-Bradley TA; Sestito AP; Vecchiola AN; Wells EE
    Exp Clin Psychopharmacol; 2018 Dec; 26(6):525-540. PubMed ID: 30035577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the NMDA receptor antagonists dizocilpine and Ro 63-1908 on delay-discounting and risky decision-making in a gambling task.
    Higgins GA; Silenieks LB; MacMillan C; Zeeb FD; Thevarkunnel S
    Behav Brain Res; 2018 Aug; 348():201-210. PubMed ID: 29689373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of N-methyl-d-aspartate receptor (NMDAr) uncompetitive antagonists in a delay discounting paradigm using a concurrent-chains procedure.
    Yates JR; Gunkel BT; Rogers KK; Breitenstein KA; Hughes MN; Johnson AB; Sharpe SM
    Behav Brain Res; 2018 Sep; 349():125-129. PubMed ID: 29604367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group I metabotropic glutamate receptor antagonists impair discriminability of reinforcer magnitude, but not risky choice, in a probability-discounting task.
    Yates JR; Chitwood MR; Evans KE; Kappesser JL; Murray CP; Paradella-Bradley TA; Torline BT
    Behav Brain Res; 2019 Jun; 365():77-81. PubMed ID: 30831139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment.
    Higgins GA; Silenieks LB; MacMillan C; Sevo J; Zeeb FD; Thevarkunnel S
    Behav Brain Res; 2016 Sep; 311():1-14. PubMed ID: 27180168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risky decision making in Attention-Deficit/Hyperactivity Disorder: A meta-regression analysis.
    Dekkers TJ; Popma A; Agelink van Rentergem JA; Bexkens A; Huizenga HM
    Clin Psychol Rev; 2016 Apr; 45():1-16. PubMed ID: 26978323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention-Deficit/Hyperactivity Disorder: Focus upon Aberrant N-Methyl-D-Aspartate Receptors Systems.
    Archer T; Garcia D
    Curr Top Behav Neurosci; 2016; 29():295-311. PubMed ID: 26718589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Think twice: Impulsivity and decision making in obsessive-compulsive disorder.
    Grassi G; Pallanti S; Righi L; Figee M; Mantione M; Denys D; Piccagliani D; Rossi A; Stratta P
    J Behav Addict; 2015 Dec; 4(4):263-72. PubMed ID: 26690621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV).
    Fujiwara E; Tomlinson SE; Purdon SE; Gill MJ; Power C
    J Clin Exp Neuropsychol; 2015; 37(7):733-50. PubMed ID: 26207583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of MK-801-induced behavioral perseveration by typical and atypical antipsychotic pretreatment in rats.
    Tuplin EW; Stocco MR; Holahan MR
    Behav Neurosci; 2015 Aug; 129(4):399-411. PubMed ID: 26052791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.
    Grados MA; Atkins EB; Kovacikova GI; McVicar E
    Psychol Res Behav Manag; 2015; 8():115-31. PubMed ID: 25995654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noradrenergic modulation of risk/reward decision making.
    Montes DR; Stopper CM; Floresco SB
    Psychopharmacology (Berl); 2015 Aug; 232(15):2681-96. PubMed ID: 25761840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent intermittent ethanol exposure is associated with increased risky choice and decreased dopaminergic and cholinergic neuron markers in adult rats.
    Boutros N; Semenova S; Liu W; Crews FT; Markou A
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25612895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroeconomics of psychopathy: risk taking in probability discounting of gain and loss predicts psychopathy.
    Takahashi T; Takagishi H; Nishinaka H; Makino T; Fukui H
    Neuro Endocrinol Lett; 2014; 35(6):510-7. PubMed ID: 25433845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of ionotropic glutamate receptors in delay and probability discounting in the rat.
    Yates JR; Batten SR; Bardo MT; Beckmann JS
    Psychopharmacology (Berl); 2015 Apr; 232(7):1187-96. PubMed ID: 25270726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.
    Pettorruso M; De Risio L; Martinotti G; Di Nicola M; Ruggeri F; Conte G; Di Giannantonio M; Janiri L
    Biomed Res Int; 2014; 2014():109786. PubMed ID: 25013755
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.